Differential expression of 17beta-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues.
about
Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid DehydrogenasesEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerStructure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenaseLigand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors.Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor modelsStepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.Bacterial Lipopolysaccharides Induce Steroid Sulfatase Expression and Cell Migration through IL-6 Pathway in Human Prostate Cancer Cells.Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implicationsCastration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.Steroid hormone synthetic pathways in prostate cancer.Circulating steroid hormones in prostate carcinogenesis. Part 2: Estrogens.Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression.Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer.Single-nucleotide polymorphisms in the 17beta-hydroxysteroid dehydrogenase genes might predict the risk of side-effects of estramustine phosphate sodium in prostate cancer patients.QSAR Study of 17β-HSD3 Inhibitors by Genetic Algorithm-Support Vector Machine as a Target Receptor for the Treatment of Prostate Cancer.Biological activity of pyrazole and imidazole-dehydroepiandrosterone derivatives on the activity of 17β-hydroxysteroid dehydrogenase.Resistance to Hormonal Therapy in Prostate Cancer.
P2860
Q26772046-4C0366C6-78A0-4509-9120-40505FC00A2AQ26777310-8161FF13-B45D-4C5F-BA61-D413E1508E55Q27643293-7D7C45E8-D22B-467F-B579-0031E59B5E42Q33953050-A0767C24-261C-4EFB-9E51-3D50F822BE54Q36275656-C0DC6F15-2393-4322-86F0-BDD4FA2D3B87Q36381291-4FD0BC86-C945-46FF-B41C-5FB78270A17DQ36617036-26C73056-9B8A-4D1E-9927-B0DD4BE62D95Q37145415-687E1F4D-A1E3-4319-8227-EC9D4EC3314FQ37159878-99F30B3D-9022-4DBA-BEF3-A5E941006482Q37469444-51523491-7014-477A-B812-35CF9AEEC1F9Q37989094-C962D942-9CB6-4306-AB66-55DF68E1857DQ38266059-1BC7B402-0EDE-4245-9F20-F921C11C544AQ38471556-59582644-2490-4C49-989A-BFC118DBA3BCQ38707335-F2E71D0B-BA28-49D3-BBA1-75EBF2B48BEAQ40154021-E4B61C62-7C99-4AE3-AC82-A4BFF584C024Q45283892-F460F13C-DB89-4255-A1B2-82D5A1804A1EQ46198562-77ABD6A9-AB70-47F0-B5D0-25A19925F1C1Q51744501-6F3E83E0-0D2B-4E83-BC01-53142CA80C23Q53393993-536588BB-A60A-4256-9633-E06840E9D422
P2860
Differential expression of 17beta-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Differential expression of 17b ...... cancer and noncancer tissues.
@en
Differential expression of 17b ...... cancer and noncancer tissues.
@nl
type
label
Differential expression of 17b ...... cancer and noncancer tissues.
@en
Differential expression of 17b ...... cancer and noncancer tissues.
@nl
prefLabel
Differential expression of 17b ...... cancer and noncancer tissues.
@en
Differential expression of 17b ...... cancer and noncancer tissues.
@nl
P2093
P2860
P356
P1433
P1476
Differential expression of 17b ...... cancer and noncancer tissues.
@en
P2093
Eitetsu Koh
Jiro Kanaya
Mikio Namiki
P2860
P304
P356
10.1002/PROS.10139
P577
2002-10-01T00:00:00Z